# Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis

> **NCT03926637** · — · TERMINATED · sponsor: **Biogen** · enrollment: 3073 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Multiple Sclerosis Performance Test (MSPT)

## Key facts

- **NCT ID:** NCT03926637
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-17
- **Primary completion:** 2022-12-05
- **Final completion:** 2022-12-05
- **Target enrollment:** 3073 (ACTUAL)
- **Why stopped:** Biogen will stop any further development of the MSPT. The data collected thus far in the MSPT Feasibility Study allow us to answer the primary study objectives that are associated with assessing the feasibility of the MSPT in a clinical care setting.
- **Last updated:** 2023-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926637, "Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03926637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*